Björn Frendéus

Company: BioInvent

Job title: Chief Scientific Officer

Seminars:

2:00 pm “All Things Fc Gamma”: Harnessing the Potential of Fc Gamma Receptors to Tune Antibody-based Immunotherapy 2:00 pm

Examining the beneficial or compromising effect of FcyRs in antibody-based cancer immunotherapies Tailored FcgR-blockade to enhance the efficacy of therapeutic antibodies Outlook inflammation – how FcgRs can be harnessed for the treatment of autoimmune and inflammatory diseaseRead more

day: Conference Day Two PM